Nonalcoholic fatty liver disease (NAFLD) is a highly prevalent form of human hepatic disease and feeding mice a high-fat, high-caloric (HFHC) diet is a standard model of NAFLD. To better understand the genetic basis of NAFLD, we conducted an expression quantitative trait locus (eQTL) analysis of mice fed a HFHC diet. Two-hundred sixty-five (A/J × C57BL/6J) F2 male mice were fed a HFHC diet for 8 wk. eQTL analysis was utilized to identify genomic regions that regulate hepatic gene expression of Xbp1s and Socs3. We identified two overlapping loci for Xbp1s and Socs3 on Chr 1 (164.0–185.4 Mb and 174.4–190.5 Mb, respectively) and Chr 11 (41.1–73.1 Mb and 44.0–68.6 Mb, respectively), and an additional locus for Socs3 on Chr 12 (109.9–117.4 Mb). ...
Nonalcoholic fatty liver disease (NAFLD) ranges from simple steatosis to hepatic inflammation to cir...
We report the genetic analysis of a “humanized” hyperlipidemic mouse model for progressive nonalcoho...
We report the genetic analysis of a “humanized” hyperlipidemic mouse model for progressive nonalcoho...
Nonalcoholic fatty liver disease (NAFLD) is a highly prevalent form of human hepatic disease and fee...
Nonalcoholic fatty liver disease (NAFLD) is a highly prevalent form of human hepatic disease and fee...
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the w...
To identify genetic and environmental factors contributing to the pathogenesis of non-alcoholic fatt...
To identify genetic and environmental factors contributing to the pathogenesis of non-alcoholic fatt...
AIMS/HYPOTHESIS: Complex changes in gene expression are associated with insulin resistance and non-a...
Non-alcoholic fatty liver disease (NAFLD) is often associated with obesity and type 2 diabetes. To d...
Multi-omics multi-tissue data are used to interpret genome-wide association study results from mice ...
Non-alcoholic fatty liver disease (NAFLD) is often associated with obesity and type 2 diabetes. To d...
Non-alcoholic fatty liver disease (NAFLD) is often associated with obesity and type 2 diabetes. To d...
Background The liver plays a major role in regulating metabolic homeostasis and is vital for nutrien...
Nonalcoholic fatty liver disease (NAFLD) ranges from simple steatosis to hepatic inflammation to cir...
Nonalcoholic fatty liver disease (NAFLD) ranges from simple steatosis to hepatic inflammation to cir...
We report the genetic analysis of a “humanized” hyperlipidemic mouse model for progressive nonalcoho...
We report the genetic analysis of a “humanized” hyperlipidemic mouse model for progressive nonalcoho...
Nonalcoholic fatty liver disease (NAFLD) is a highly prevalent form of human hepatic disease and fee...
Nonalcoholic fatty liver disease (NAFLD) is a highly prevalent form of human hepatic disease and fee...
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the w...
To identify genetic and environmental factors contributing to the pathogenesis of non-alcoholic fatt...
To identify genetic and environmental factors contributing to the pathogenesis of non-alcoholic fatt...
AIMS/HYPOTHESIS: Complex changes in gene expression are associated with insulin resistance and non-a...
Non-alcoholic fatty liver disease (NAFLD) is often associated with obesity and type 2 diabetes. To d...
Multi-omics multi-tissue data are used to interpret genome-wide association study results from mice ...
Non-alcoholic fatty liver disease (NAFLD) is often associated with obesity and type 2 diabetes. To d...
Non-alcoholic fatty liver disease (NAFLD) is often associated with obesity and type 2 diabetes. To d...
Background The liver plays a major role in regulating metabolic homeostasis and is vital for nutrien...
Nonalcoholic fatty liver disease (NAFLD) ranges from simple steatosis to hepatic inflammation to cir...
Nonalcoholic fatty liver disease (NAFLD) ranges from simple steatosis to hepatic inflammation to cir...
We report the genetic analysis of a “humanized” hyperlipidemic mouse model for progressive nonalcoho...
We report the genetic analysis of a “humanized” hyperlipidemic mouse model for progressive nonalcoho...